# Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

> **NCT00353860** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 70 (actual)

## Conditions studied

- Immunosuppression
- Leukemia

## Interventions

- **DEVICE:** SOLEX 300i Stem Cell Selection

## Key facts

- **NCT ID:** NCT00353860
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01-23
- **Primary completion:** 2007-11-29
- **Final completion:** 2007-11-29
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2019-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00353860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00353860, "Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00353860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*